Integrin α6β4 is a membrane protein which is expressed in both normal and cancerous epithelia. In normal cells, it is involved in adhesion to the basal membrane. In carcinomas, however, it takes on cell signaling roles related to survival and migration. Due to its key role in cancer progression, it is now being considered as a therapeutic target. This paper examines how we can affect integrins, with a specific focus on integrin α6β4, to reinforce their ability to prevent migration of cancer cells and progress toward metastasis.
Singer, P. (2020). Treating Carcinomas through Integrin α6β4 Modification and Inhibition. The Science Journal of the Lander College of Arts and Sciences, 14(1), 45-51. Retrieved from https://touroscholar.touro.edu/sjlcas/vol14/iss1/5